News

A new study has reported that the development of schizophrenia may be associated with changes to the vasculature of certain brain regions.

Researchers with the SFU Nanodevice Fabrication Group are developing a new biosensor that can be used to screen for Alzheimer’s disease and other diseases.

In a world first international study led by Monash University researchers in Australia, the genetic markers for people with diabetes at risk of developing kidney disease have been identified.

According to a study, a new blood test can track and follow the neurodegeneration in Alzheimer's disease – and exclude other dementias.

Selecting an appropriate sample preparation method can improve the efficiency and accuracy of mold identification, and researchers have now evaluated three different MALDI-TOF MS approaches for the identification of molds.

A new test that "fishes" for multiple respiratory viruses at once using single strands of DNA as "bait", and gives highly accurate results in under an hour, has been developed by Cambridge researchers.

For over a decade scientists have studied these epigenetic modifications to test associations with disease. Now, a team of researchers reveals that the tool that has been the workhorse for these studies may not actually be appropriate for population epigenetics.

Short-chain fatty acids detected in blood samples may provide biomarkers for complications like gestational diabetes and pre-eclampsia.

Neuroimaging technology has been shown to hold great promise in helping clinicians link specific symptoms of mental health disorders to abnormal patterns of brain activity. But a new Yale-led study shows there are still kinks to be ironed out before doctors can translate images of the brain to psychiatric disorders such as post-traumatic stress disorder (PTSD).

Researchers have developed an optimized genetic test for ovarian cancer, which helps accurately target an effective but expensive medication.